Delivery Order SPE2DB20D2002-SPE2DB25FL78H
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,369.33 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML Vial, a hepatitis B vaccine product. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,149.00 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This firm fixed-price delivery order, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a competitively awarded, non-set-aside contract. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $23,145.08 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,073.02 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML, a hepatitis B vaccine, on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $19,159.17 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract, awarded on September 25, 2025, is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20MCG 10S (a hepatitis B vaccine) with a ceiling value of $1,068.75 under a firm fixed price contract. The award was made on September 8, 2025, with an ultimate completion date of the same day, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive, non-set-aside award to the prime...
- The Defense Logistics Agency awarded a delivery order valued at $4,830.31 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for vaccine supplies to...
- The Defense Logistics Agency awarded a $12,635.85 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This competitive award, issued without set-aside designation, is classified as a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...